Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug–Drug Interaction Between Voriconazole and Flucloxacillin-Reference-Cited by-同舟云学术

Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug–Drug Interaction Between Voriconazole and Flucloxacillin

Published:2024-09-14 Issue: Volume: Page:
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Abdullah-Koolmees Heshu^ORCID,van den Nieuwendijk Julia F.,Hoope Simone M. K. ten,de Leeuw David C.,Franken Linda G. W.,Said Medhat M.,Seefat Maarten R.,Swart Eleonora L.,Hendrikse N. Harry,Bartelink Imke H.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13318-024-00916-1.pdf

Reference53 articles.

1. Azevedo MM, Teixeira-Santos R, Silva AP, Cruz L, Ricardo E, Pina-Vaz C, Rodrigues AG. The effect of antibacterial and non-antibacterial compounds alone or associated with antifugals upon fungi. Front Microbiol. 2015;3(6):669. https://doi.org/10.3389/fmicb.2015.00669.

2. Voriconazole: National Library of Medicine. MedlinePlus [Internet]. Medlineplus.gov. [cited 2024 Aug 12]. Available from: https://medlineplus.gov/

3. Flucloxacillin 500mg Capsules - Summary of Product Characteristics (SmPC) - Homepage [Internet]. European Medicines Agency (EMA). [cited 2024 Aug 12]. Available from: https://www.ema.europa.eu/en/homepage

4. Kennedy B, Larcombe R, Chaptini C, Gordon DL. Interaction between voriconazole and flucloxacillin during treatment of disseminated Scedosporium apiospermum infection. J Antimicrob Chemother. 2015;70(7):2171–3. https://doi.org/10.1093/jac/dkv069.

5. Van Daele R, Wauters J, De Cock P, Buyle F, Leys J, Van Brantegem P, et al. Concomitant treatment with voriconazole and flucloxacillin: a combination to avoid. Antibiotics (Basel). 2021;10(9):1112. https://doi.org/10.3390/antibiotics10091112.